Glyzimac OD 60

Glyzimac-OD 60 combines Gliclazide (60 mg) and Metformin Hydrochloride (500 mg) in an extended-release formulation, designed for effective management of type 2 diabetes mellitus. Gliclazide stimulates insulin secretion from the pancreas, while Metformin enhances insulin sensitivity and reduces glucose production in the liver. This synergistic combination helps achieve better glycemic control, ensuring stable blood sugar levels throughout the day and minimizing the risk of complications associated with diabetes.